Compounds > triphenylselenonium chloride
Page last updated: 2024-09-25

triphenylselenonium chloride

Description

triphenylselenonium chloride: possesses significant chemopreventive activity against chemically-induced mammary carcinogenesis [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID145836
SCHEMBL ID1158021
MeSH IDM0244944

Synonyms (11)

Synonym
selenonium, triphenyl-, chloride
selenonium, chloride
nsc36783
triphenylselenonium chloride
6158-73-2
nsc-36783
triphenylselanium chloride
nsc 36783
triphenylselenoniumchloride
SCHEMBL1158021
DTXSID60977168

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (9.09)18.2507
2000's2 (18.18)29.6817
2010's7 (63.64)24.3611
2020's1 (9.09)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceDescriptionRelationhip StrengthStudiesTrialsClassesRoles
pyrroles[no description available]medium10pyrrole;
secondary amine
warfarin[no description available]medium10benzenes;
hydroxycoumarin;
methyl ketone
coumarin[no description available]medium10coumarinsfluorescent dye;
human metabolite;
plant metabolite
azides[no description available]medium10pseudohalide anionmitochondrial respiratory-chain inhibitor
benzyl chloride[no description available]medium10benzyl chlorides
piperazine[no description available]medium10azacycloalkane;
piperazines;
saturated organic heteromonocyclic parent		anthelminthic drug
naphthalimides[no description available]medium10
tempo[no description available]medium10aminoxyls;
piperidines		catalyst;
ferroptosis inhibitor;
radical scavenger
cytochrome c-t[no description available]medium10
firefly luciferin[no description available]medium101,3-thiazolemonocarboxylic acid;
benzothiazoles;
imidothioate		luciferin
sodium selenite[no description available]medium20inorganic sodium salt;
selenite salt		nutraceutical
selenium[no description available]medium20chalcogen;
nonmetal atom		micronutrient
methylnitrosourea[no description available]medium30N-nitrosoureasalkylating agent;
carcinogenic agent;
mutagen;
teratogenic agent
selenocysteine[no description available]medium10
bromodeoxyuridine[no description available]medium10pyrimidine 2'-deoxyribonucleosideantimetabolite;
antineoplastic agent
cysteine[no description available]medium10cysteiniumfundamental metabolite
selenomethylselenocysteine[no description available]medium10non-proteinogenic alpha-amino acid;
selenocysteines		antineoplastic agent;
human metabolite
ConditionIndicatedRelationship StrengthStudiesTrials
Benign Neoplasms, Brain0low10
Brain Cancer0low10
Brain Metastases0low10
Brain Neoplasm, Primary0low10
Brain Neoplasms0low10
Brain Neoplasms, Benign0low10
Brain Neoplasms, Malignant0low10
Brain Neoplasms, Malignant, Primary0low10
Brain Neoplasms, Primary Malignant0low10
Brain Tumor, Primary0low10
Brain Tumor, Recurrent0low10
Brain Tumors0low10
Cancer of Brain0low10
Cancer of Cervix0low10
Cancer of the Brain0low10
Cancer of the Cervix0low10
Cancer of the Uterine Cervix0low10
Cell Transformation, Neoplastic0low10
Cervical Cancer0low10
Cervical Neoplasms0low10
Cervix Cancer0low10
Cervix Neoplasms0low10
Condition, Preneoplastic0low10
Conditions, Preneoplastic0low10
Electron Transport Chain Deficiencies, Mitochondrial0low10
Experimental Mammary Neoplasms0low10
Glial Cell Tumors0low10
Glioma0low10
Intracranial Neoplasms0low10
Malignant Glioma0low10
Malignant Neoplasms, Brain0low10
Malignant Primary Brain Neoplasms0low10
Malignant Primary Brain Tumors0low10
Mammary Neoplasms, Experimental0low10
Mitochondrial Diseases0low10
Mitochondrial Disorders0low10
Mitochondrial Electron Transport Chain Deficiencies0low10
Mitochondrial Respiratory Chain Deficiencies0low10
Mixed Glioma0low10
Neoplasms, Brain0low10
Neoplasms, Brain, Benign0low10
Neoplasms, Brain, Malignant0low10
Neoplasms, Brain, Primary0low10
Neoplasms, Cervical0low10
Neoplasms, Cervix0low10
Neoplasms, Experimental Mammary0low10
Neoplasms, Intracranial0low10
Neoplastic Cell Transformation0low10
Neoplastic Transformation, Cell0low10
Oxidative Phosphorylation Deficiencies0low10
Precancerous Conditions0low10
Preneoplastic Condition0low10
Preneoplastic Conditions0low10
Primary Brain Neoplasms0low10
Primary Malignant Brain Neoplasms0low10
Primary Malignant Brain Tumors0low10
Respiratory Chain Deficiencies, Mitochondrial0low10
Transformation, Neoplastic Cell0low10
Tumorigenic Transformation0low10
Uterine Cervical Cancer0low10
Uterine Cervical Neoplasms0low10

Research Highlights

Safety/Toxicity (1)

ArticleYear
pH-Sensitive micelles with mitochondria-targeted and aggregation-induced emission characterization: synthesis, cytotoxicity and biological applications.
Biomaterials science, Nov-01, Volume: 6, Issue: 11		2018
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioavailability (2)

ArticleYear
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Dosage (1)

ArticleYear
Selenium modulation of cell proliferation and cell cycle biomarkers in normal and premalignant cells of the rat mammary gland.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, Volume: 9, Issue: 1		2000
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]